475i Rifaximin Treatment for 2 Weeks Provides Acute and Sustained Relief Over 12 Weeks of IBS Symptoms in Non-Constipated Irritable Bowel Syndrome: Results From 2 North American Phase 3 Trials (Target 1 and Target 2)

Authors :: William P. Forbes
Mark Pimentel
Audrey L. Shaw
Enoch Bortey
Jing Yu
Salam Zakko
Yehuda Ringel
William D. Chey
Anthony Lembo
Shadreck M. Mareya
Source :: Gastroenterology. 138:S-64
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: medicine.medical_specialty
chemistry.chemical_compound
Hepatology
chemistry
business.industry
Internal medicine
Gastroenterology
medicine
medicine.disease
business
Irritable bowel syndrome
Rifaximin

Tools